macrogol

DRUG5 trials

Conditions

Diffuse Cutaneous Systemic SclerosisHip fractureIdiopathic Pulmonary FibrosisMicrobiotaSubjects scheduled for elective colonoscopy performed according to ESGE (European Society of Gastrointestinal Endoscopy) guidelines.

Phase 2

A Phase 2b Randomized, Double-blind, Placebo-controlled, Repeat-dose, Multicenter Trial to Evaluate the Efficacy, Safety and Tolerability of HZN-825 in Subjects with Idiopathic Pulmonary Fibrosis

CompletedCTIS2023-509784-24-00

Horizon Therapeutics Ireland Designated Activity CompanyIdiopathic Pulmonary Fibrosis

Start: 2022-05-11End: 2024-10-30Target: 17Updated: 2024-12-18

A Randomized, Double-blind, Placebo-controlled, Repeat-dose, Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients with Diffuse Cutaneous Systemic Sclerosis [HZNP-HZN-825-301]

CompletedCTIS2023-509782-20-00

Horizon Therapeutics Ireland Designated Activity CompanyDiffuse Cutaneous Systemic Sclerosis

Start: 2021-11-11End: 2024-12-19Target: 84Updated: 2025-02-25

Phase 3

A phase III, international, multiCenter, randomized, paraLlel-group, Endoscopist-blinded non-inferiority study of the efficAcy, safety and patient acceptance of mannitol veRsus Plenvu® in boWel prepAration for elective colonoscopY. CLEARWAY

RecruitingCTIS2025-521451-23-00

Ntc S.r.l.Subjects scheduled for elective colonoscopy performed according to ESGE (European Society of Gastrointestinal Endoscopy) guidelines.

Start: 2025-09-03Target: 520Updated: 2025-12-12

Phase 4

Oral laxatives after hip fracture surgery: A randomised controlled trial

RecruitingCTIS2024-513871-42-00

Odense University HospitalHip fracture

Start: 2024-10-01Target: 375Updated: 2025-07-08

Unknown Phase

Stability of the Microbiome in IBD and IBS

CompletedNCT03395548

Medical University of GrazMicrobiota